$ALNY
Price history, market instrument context, member research, and related headlines in one place.
ALNY key statistics
NasdaqGSUSD
52-week range
$197.8112%$495.55
Latest session $228.12–$233.97Alnylam Pharmaceuticals, Inc. (ALNY) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $233.91, up $9.44 (4.20%) from the previous close of $224.47. It has traded between $228.12 and $233.97 in the latest session. Over the past year it has ranged from $197.81 to $495.55, leaving it in the lower quarter of its 52-week range (12%). Reported volume for the session was 602K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Alnylam initiated an outperform at BMO on RNAi pipeline — See source for full details.
Alnylam stock rating upgraded to Strong Buy at Raymond James on pipeline potential — See source for full details.
Alnylam forecasts $4.7B-$5.1B in 2026 product revenue while targeting 25% TTR revenue CAGR through 2030 — See source for full details.
Alnylam Q2 2026 slides show strong growth amid guidance cut, stock plunge — See source for full details.
Alnylam drops after guidance cut on ATTR-CM headwinds — See source for full details.
Alnylam Pharmaceuticals misses Q2 street views — See source for full details.
Loading $ALNY research…